Discover Germany, Issue 55, October 2017

Page 23

Discover Germany  |  Advertorial  |  Berlin: The Biotech Capital

Deutschland GmbH, recently said in an interview with www.healthcapital.de. “We support the scientific community and are involved in many different conferences to make Berlin an attractive city of science.” This also includes innovative research projects with the well-known Berlin Charité hospital, investigating current medical problems like strokes and diabetes.

are the short distances between research facilities and the good public transport network, which means other research facilities are never far away and always easy to reach. In short, Berlin is an excellent location for research in biotech, life sciences and medicine.

The Charité is one of the largest university hospitals in Europe and speaks of the long history the city has in researching and solving medical problems. The hospital has its original roots in the early 18th century when the Prussian king Friedrich I ordered the establishment of hospitals outside the city’s borders to prepare for contagious infections. In the 19th century, while still independent from the university, the hospital had a practical approach in educating new doctors. Today more than 4,500 physicians and scientists carry out research, teach and treat patients here at the cutting edge of international medicine. The university hospital procures more third-party funding than any other medical training facility in Germany.

Next to the well-known Charité hospital, the region is home to 41 renowned scientific institutions: The Robert Koch Institute, the Max Delbrück Center (MDC) for Molecular Medicine, the Deutsches Herzzentrum Berlin (DHZB) and various Fraunhofer, Helmholtz, Leibniz and Max Planck Institutes. Scientists from the Charité and the Max Delbrück Center (MDC) for Molecular Medicine have been carrying out joint research at the Berlin Institute of Health (BIH) since 2013. The BIH is a scientific institution for translational research and systems medicine, a unique structure in Germany’s biomedical research landscape.

With its open atmosphere and international feel, Berlin offers ideal conditions for project-related co-operations between basic researchers, technology developers and clinical researchers. What also helps Charité. Photo: © Charité-Universitätsmedizin Berlin

An innovation hub that attracts young start-ups

But next to all these established research institutions and companies, Berlin also attracts various young start-ups launched by talented young researchers. An example for that is Cellbricks (www.cellbricks.com), a company that focuses on 3D bioprinting, an innovative and key technology where cell structures are 3D-printed to simulate

human tissues and organs. One intention is to make animal-based drug testing obsolete by using artificial tissue, but also to revolutionise today’s medical treatments. To again show how important life sciences are for the German capital: One in eight Berlin citizens is employed in the healthcare sector. Colleges and universities in Berlin are offering 208 training programmes in health-related subjects alone. Additionally, the political decision makers and relevant federal government institutions are just around the corner, as are patient organisations and health insurers. www.healthcapital.de Business and technology support for companies, investors and scientific institutions in Berlin – this is the Berlin Partner für Wirtschaft und Technologie GmbH‘s mission. With customised services and an excellent science and research network, their many experts provide an outstanding range of programmes to help companies launch, innovate, expand and secure their economic future in Berlin. In this function, Berlin Partner is also responsible for managing the cluster HealthCapital. www.berlin-partner.de www.healthcapital.de

Photo: © Berlin Partner

Issue 55  |  October 2017  |  23